Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: A comparison of six cohorts

International Journal of Geriatric Psychiatry

Volumn 28, Issue 8, 2013, Pages 868-876

  Ruths, Sabine ^a,b   Sørensen, Pernille Hegre ^c   Kirkevold, Øyvind ^d,e,f   Husebø, Bettina S ^b,g   Krüger, Kjell ^h   Halvorsen, Kjell H ⁱ   Selbæk, Geir ^e,j  

^a Research Unit for General Practice   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Stavanger Hospital   (Norway)

^d VESTFOLD HOSPITAL TRUST   (Norway)

^e INNLANDET HOSPITAL TRUST   (Norway)

^f UNIVERSITY OF AGDER   (Norway)

^g STAVANGER UNIVERSITY HOSPITAL   (Norway)

^h Municipality of Bergen ^*  (Norway)

ⁱ UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^j AKERSHUS UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

antidepressants; antipsychotics; anxiolytics; hypnotics; nursing homes

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGE; AGED; ARTICLE; CLINICAL PRACTICE; DRUG UTILIZATION; FEMALE; GENDER; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; NURSING HOME; NURSING HOME PATIENT; PRESCRIPTION; PREVALENCE; PSYCHOPHARMACOTHERAPY; RESIDENCY EDUCATION; SEX DIFFERENCE; TREND STUDY; WARD;

ANTIDEPRESSANTS; ANTIPSYCHOTICS; ANXIOLYTICS; HYPNOTICS; NURSING HOMES;

AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; NORWAY; NURSING HOMES; PSYCHOTROPIC DRUGS;

EID: 84879986116     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3902     Document Type: Article

References (47)

1. Ballard CG, Thomas A, Fossey J, et al,. 2004. A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry 65: 114-119.
2. Banerjee S, Hellier J, Dewey M, et al,. 2011. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 378: 403-411.
3. Barca ML, Engedal K, Laks J, Selbaek G,. 2010. A 12 months follow-up study of depression among nursing-home patients in Norway. J Affect Disord 120: 141-148.
4. Bergh S, Selbæk G, Engedal K,. Mar 9 2012. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial. BMJ 344: e1566. doi: 10.1136/bmj.e1566.
5. van den Brand MW, Pouwels S, Samson MM, et al,. 2009. Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int 20: 1705-1713.
6. Coupland C, Dhiman P, Morriss R, et al,. 2011. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343: d4551. doi: 10.1136/bmj.d4551.
7. Gaboda D, Lucas J, Siegel M, et al,. 2011. No longer undertreated? Depression diagnosis and antidepressant therapy in elderly long-stay nursing home residents. J Am Geriatr Soc 59: 673-680. DOI: 10.1111/j.1532-5415.2011. 03322.x.
8. Gallagher P, O'Mahony D,. 2008. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 37: 673-679.
9. Halvorsen KH, Ruths S, Granas AG, Viktil KK,. 2010. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scand J Prim Health Care 28: 82-88.
10. Hosia-Randell H, Pitkälä K,. 2005. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 22: 793-800.
11. Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A,. 2003. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 158: 77-84.
12. Husebøbo BS, Ballard C, Sandvik R, et al,. 2011. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ 343: d4065. doi: 10.1136/bmj.d4065.
13. Huybrechts KF, Rothman KJ, Silliman RA, Brookhart MA, Schneeweiss S,. 2011. Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. CMAJ 183: E411-419.
14. Iden KR, Hjørleifsson S, Ruths S,. 2011. Treatment decisions on antidepressants in nursing homes: a qualitative study. Scand J Prim Health Care 29: 252-256.
15. Kales HC, Valenstein M, Kim HM, et al,. 2007. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry 164: 1568-1576.
16. Kales HC, Zivin K, Kim HM, et al,. 2011. Trends in antipsychotic use in dementia 1999-2007. Arch Gen Psychiatry 68: 190-197.
17. Kamble P, Chen H, Sherer J, Aparasu RR,. 2008. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother 6: 187-197.
18. Kamble P, Sherer J, Chen H, Aparasu RR,. 2010. Off-label use of second-generation antipsychotic agents among nursing home residents. Psychiatr Serv 61: 130-136.
19. Karkare SU, Bhattacharjee S, Kamble P, Aparasu R,. 2011. Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am J Geriatr Pharmacother 9: 109-119.
20. Kirkevold O, Engedal K,. 2009. Is covert medication in Norwegian nursing homes still a problem? A cross-sectional study. Drugs Aging 26: 333-344.
21. Kirkevold O, Sandvik L, Engedal K,. 2004. Use of constraints and their correlates in Norwegian nursing homes. Int J Geriatr Psychiatry 19: 980-988.
22. Krüger K, Folkestad M, Geitung JT, Eide GE, Grimsmo A,. 2012. Psychoactive drugs in seven nursing homes. Prim Health Care Res Dev 00: 1-11 doi: 10.1017/S1463423611000685
23. Lindström K, Ekedahl A, Carlsten A, et al,. 2007. Can selective serotonin inhibitor drugs in elderly patients in nursing homes be reduced? Scand J Prim Health Care 25: 3-8.
24. Lövheim H, Sandman PO, Karlsson S, Gustafson Y,. 2009. Changes between 1982 and 2000 in the prevalence of behavioral symptoms and psychotropic drug treatment among old people with cognitive impairment in geriatric care. Int Psychogeriatr 21: 941-948.
25. Lövheim H, Gustafson Y, Karlsson S, Sandman PO,. 2011. Comparison of behavioral and psychological symptoms of dementia and psychotropic drug treatments among old people in geriatric care in 2000 and 2007. Int Psychogeriatr 23: 1616-1622.
26. Lustenberger I, Schüpbach B, von Gunten A, Mosimann U,. Oct 4 2011. Psychotropic medication use in Swiss nursing homes. Swiss Med Wkly 141: w13254. doi: 10.4414/smw.2011.13254.
27. Maher AR, Maglione M, Bagley S, et al,. 2011. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA 306: 1359-1569.
28. Mann E, Köpke S, Haastert B, Pitkälä K, Meyer G,. 2009. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr 9: 18.
29. Nelson JC, Devanand DP,. 2011. A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia. J Am Geriatr Soc 59: 577-585.
30. Norwegian Drug and Therapeutic Formulary for Health Personnel. 2011. Drug treatment for older people., Fjeldstad T, (ed.). http://legemiddelhandboka.no/ (accessed 28.09.2012).
31. Norwegian Institute of Public Health. 2009. The Norwegian prescription database. Available at http://www.norpd.no/
32. Nygaard HA, Naik M, Ruths S, Straand J,. 2004. Not less but different: psychotropic drug utilization trends in Norwegian nursing homes during a 12-year period. The Bergen District Nursing Home (BEDNURS) Study. Aging Clin Exp Res 16: 277-282.
33. Olsson J, Bergman A, Carlsten A, et al,. 2010. Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis. Clin Drug Investig 30: 289-300.
34. Rosenvinge BH, Rosenvinge JH,. 2003. Occurrence of depression in the elderly-a systematic review of 55 prevalence studies from 1990 to 2001. Tidsskr Nor Laegeforen 123: 928-929.
35. Ruths S, Straand J, Nygaard HA,. 2001. Psychotropic drug use in nursing homes-diagnostic indications and variations between institutions. Eur J Clin Pharmacol 57: 523-528.
36. Ruths S, Straand J, Nygaard HA, et al,. 2004. Impact of antipsychotic withdrawal on behavior and sleep/wake activity in demented nursing home residents. The Bergen District Nursing Home (BEDNURS) Study. J Am Geriatr Soc 52: 1737-1743.
37. Schmidt IK, Claesson CB, Westerholm B, et al,. 1998. The impact of multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 46: 77-82.
38. Schneider LS, Dagerman KS, Insel P,. 2005. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294: 1934-1943.
39. Schneider LS, Dagerman K, Insel PS,. 2006. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 14: 191-210.
40. Selbaek G, Kirkevold Ø, Engedal K,. 2007. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriatr Psychiatry 22: 843-849.
41. Statistics Norway. 2012. StatBank Norway. http://statbank.ssb.no// statistikkbanken/default-fr.asp?PLanguage=1 (accessed 18.05.2012)
42. Testad I, Auer S, Mittelman M, et al,. 2009. Nursing home structure and associations with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England. Int J Geriatr Psychiatry 25: 725-731.
43. The Norwegian Directorate of Health. 2011. Key figures for the health sector. http://helsedirektoratet.no/Om/nyheter/Sider/nokkeltall-for- helsesektoren-2011.aspx (accessed 28.09.2012)
44. Wang PS, Schneeweiss S, Avorn J, et al,. 2005. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. NEJM 353: 2335-2341.
45. Wood-Mitchell A, James IA, Waterworth A, et al,. 2008. Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. Age Ageing 37: 547-552.
46. World Health Organization Anatomical Therapeutic Chemical (ATC) classification index. 2010. World Health Organization Collaborating Centre for Drug Statistics Methodology, Oslo. http://www.whocc.no/atc-ddd-index/ (accessed 18.05.2012).
47. Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT,. 2011. Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians' prescription behavior. Int Psychogeriatr 23: 1632-1639.